Crestwood Advisors Group LLC Exact Sciences Corp Transaction History
Crestwood Advisors Group LLC
- $5.07 Billion
- Q3 2024
A detailed history of Crestwood Advisors Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Crestwood Advisors Group LLC holds 4,313 shares of EXAS stock, worth $227,295. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,313Holding current value
$227,295% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding EXAS
# of Institutions
670Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$936 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$835 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$755 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$636 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$352 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.33B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...